Clinical & Experimental Metastasis

Clinical & Experimental Metastasis

临床和实验性转移

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Clinical & Experimental Metastasis》是由Springer Netherlands出版社于1983年创办的英文国际期刊(ISSN: 0262-0898,E-ISSN: 1573-7276),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为医学-肿瘤学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比69.57%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在46篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical & Experimental Metastasis审稿周期约为 约12月 。该刊近年未被列入国际预警名单,年发文量约46篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 46 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 89 / 322

72.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 130 / 322

59.78%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.8 SJR:1.216 SNIP:0.944
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 84 / 404

79%

大类:Medicine 小类:Cancer Research Q2 75 / 230

67%

期刊发文

  • Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma

    Author: Zhiming Dong, Xiaoliang Liang, Xuan Wu, Xiaoliang Kang, Yanli Guo, Supeng Shen, Jia Liang, Wei Guo

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2019, Vol., , DOI:10.1007/s10585-019-09964-3

  • Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer

    Author: Wu-gui Chen, Jing Sun, Wei-wei Shen, Si-zhen Yang, Ying Zhang, Xu Hu, Hao Qiu, Shang-cheng Xu, Tong-wei Chu

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2019, Vol., , DOI:10.1007/s10585-018-9951-5

  • Lung cancer with bone metastases in the United States: an analysis from the Surveillance, Epidemiologic, and End Results database

    Author: Wangmi Liu, Jiayan Wu

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2018, Vol.35, 753-761, DOI:10.1007/s10585-018-9943-5

  • Long non-coding RNA p10247, high expressed in breast cancer ( lncRNA-BCHE), is correlated with metastasis

    Author: Yu-Xia Yang, Li Wei, Yan-Ju Zhang, Takahide Hayano, María del Pilar Piñeiro Pereda, Hirofumi Nakaoka, Qiang Li, Isabel Barragán Mallofret, Yuan-Zhi Lu, Luca Tamagnone, Ituro Inoue, Xiangdong Li, Jian-Yuan Luo, Ke Zheng, Hua You

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2018, Vol., , DOI:10.1007/s10585-018-9901-2

  • Ecto-5′-nucleotidase (CD73) promotes tumor angiogenesis

    Author: Li Wang, Shaoxian Tang, Yingjian Wang, Siguang Xu, Jerry Yu, Xiuling Zhi, Zhouluo Ou, Jiayin Yang, Ping Zhou, Zhimin Shao

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2013, Vol.30, 671-680, DOI:10.1007/s10585-013-9571-z

  • eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation

    Author: Chao Xu, Duan-min Hu, Qi Zhu

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2013, Vol.30, 933-944, DOI:10.1007/s10585-013-9593-6

  • Expression of HOXD3 correlates with shorter survival in patients with invasive breast cancer

    Author: Cheng Shaoqiang, Zhang Yue, Liu Yang, Zhao Hong, Zhen Lina, Pang Da, Zhang Qingyuan

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2012, Vol.30, 155-163, DOI:10.1007/s10585-012-9524-y

  • RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma

    Author: Wei Guo, Cong Wang, Yanli Guo, Supeng Shen, Xin Guo, Gang Kuang, Zhiming Dong

    Journal: CLINICAL & EXPERIMENTAL METASTASIS, 2015, Vol.32, 83-98, DOI:10.1007/s10585-015-9693-6